Lessons from past radiation accidents: Critical review of methods addressed to individual dose assessment of potentially exposed people and integration with medical assessment.

Chernobyl Dose assessment Dosimetry Fukushima Nuclear reactor accident Radiological emergency

Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
01 2021
Historique:
received: 30 06 2020
revised: 25 09 2020
accepted: 30 09 2020
pubmed: 19 10 2020
medline: 22 4 2021
entrez: 18 10 2020
Statut: ppublish

Résumé

The experiences of the Chernobyl and Fukushima nuclear accidents showed that dosimetry was the essential tool in the emergency situation for decision making processes, such as evacuation and application of protective measures. However, at the consequent post-accidental phases, it was crucial also for medical health surveillance and in further adaptation to changed conditions with regards to radiation protection of the affected populations. This review provides an analysis of the experiences related to the role of dosimetry (dose measurements, assessment and reconstruction) regarding health preventive measures in the post-accidental periods on the examples of the major past nuclear accidents such as Chernobyl and Fukushima. Recommendations derived from the review are called to improve individual dose assessment in case of a radiological accident/incident and should be considered in advance as guidelines to follow for having better information. They are given as conclusions.

Identifiants

pubmed: 33069983
pii: S0160-4120(20)32130-9
doi: 10.1016/j.envint.2020.106175
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106175

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Joan Francesc Barquinero (JF)

UAB - Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain. Electronic address: Francesc.Barquinero@uab.cat.

Paola Fattibene (P)

ISS - Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

Vadim Chumak (V)

NRCRM - National Research Center for Radiation Medicine, 04050 Kyiv, Ukraine.

Takashi Ohba (T)

FMU - Fukushima Medical University, 1 Hikarigaoka, 9601295 Fukushima, Japan.

Sara Della Monaca (S)

ISS - Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

Cristina Nuccetelli (C)

ISS - Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.

Keiichi Akahane (K)

QST-NIRS - National Institutes of Quantum and Radiological Science and Technology-National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 2638555, Japan.

Osamu Kurihara (O)

QST-NIRS - National Institutes of Quantum and Radiological Science and Technology-National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 2638555, Japan.

Kenji Kamiya (K)

HiroshimaU - Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima City 7348551, Hiroshima, Japan.

Atsushi Kumagai (A)

QST-NIRS - National Institutes of Quantum and Radiological Science and Technology-National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 2638555, Japan.

Cecile Challeton-de Vathaire (C)

IRSN - Institut de Radioprotection et de Sûreté Nucléaire, 92260 Fontenay-aux-Roses, France.

Didier Franck (D)

IRSN - Institut de Radioprotection et de Sûreté Nucléaire, 92260 Fontenay-aux-Roses, France.

Eric Gregoire (E)

IRSN - Institut de Radioprotection et de Sûreté Nucléaire, 92260 Fontenay-aux-Roses, France.

Christiane Poelzl-Viol (C)

BfS - Bundesamt fuer Strahlenschutz, 85764 Oberschleißheim, Germany.

Ulrike Kulka (U)

BfS - Bundesamt fuer Strahlenschutz, 85764 Oberschleißheim, Germany.

Ursula Oestreicher (U)

BfS - Bundesamt fuer Strahlenschutz, 85764 Oberschleißheim, Germany.

Marion Peter (M)

BfS - Bundesamt fuer Strahlenschutz, 85764 Oberschleißheim, Germany.

Alicja Jaworska (A)

DSA - Norwegian Radiation and Nuclear Safety Authority, Norway.

Liudmila Liutsko (L)

ISGlobal - Instituto de Salud Global de Barcelona, 08003 Barcelona, Spain; UPF- Universitat Pompeu Fabra, 08003 Barcelona, Spain; Spanish Consortium for Research and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

Koichi Tanigawa (K)

Futaba Medical Center, 817-1 Otsuka, Moto-oka, Futaba Town, 9791151 Fukushima, Japan.

Elisabeth Cardis (E)

ISGlobal - Instituto de Salud Global de Barcelona, 08003 Barcelona, Spain; UPF- Universitat Pompeu Fabra, 08003 Barcelona, Spain; Spanish Consortium for Research and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH